Investigating fasting for metabolic health and longevity.
Level 5 - mechanism / opinion, no new human data
Narrative review and expert perspective without systematic methodology or primary human data.
PubMed 42043665 · doi:10.1007/s10522-026-10438-9
What was done
This paper presents a narrative perspective and review evaluating the rationale, current evidence base, safety considerations, and future study frameworks regarding intermittent fasting and time-restricted eating for metabolic health and longevity.
What was found
The abstract reports no numerical findings or quantitative statistics. The authors conclude that longevity benefits from fasting remain unproven in humans and evidence is insufficient for widespread adoption. However, they note that intermittent fasting or time-restricted eating is reasonable for motivated patients with overweight or obesity, provided they do not have risk factors such as frailty, osteopenia, osteoporosis, or current/past eating disorders.
Why it matters
It provides a balanced clinical perspective distinguishing plausible weight-loss utility from unproven longevity claims, while outlining the mechanistic and multi-omics research designs required to establish proof-of-concept for fasting interventions or fasting-mimetic therapeutics.
Limits
This is a non-systematic narrative perspective presenting no new empirical human data or quantitative pooling. Potential long-term impacts on human lifespan and healthspan remain unmeasured.
Cited by
- context Intermittent fasting extends human lifespan.